GM-CSF Cosmeceutical Compositions and Methods of Use Thereof (Patent Application)

U.S. Patent Application No. 20090191156
Inventor: Harold Brem and Marjana Tomic-Canic
July 30, 2009

This patent involves the use of granulocyte macrophage colony stimulating factor (GM-CSF) as a regenerative therapy for healing chronic wounds. One of the major biological roles of GM-CSF that has important implication on wound healing is its ability to promote migration of keratinocytes to wound sites. Moreover, GM-CSF enhances fibroblast proliferation as well as both the quantity and quality of collagen. This invention has demonstrated the reversal of skin impairment in multiple animal models when GM-CSF was incorporated into a delivery vehicle and diabetic skin wounds were treated with an effective amount of GM-CSF over an effective time period. The treatment resulted not only in induced collagen deposition but also promoted its proper alignment. GM-CSF is now one of the standard growth-factor therapies used to treat chronic wounds at the Winthrop-University Hospital Wound Healing Center.

Click on the following link to visit the U.S. Patent Office website and read the full description of this patent application.

item1a1
item8
item8 item8
item8
item10
item19